Discontinuation of disease-modifying therapy in MS patients over 60 years old and its impact on relapse rate and disease progression - Concepedia

Concepedia

Publication | Closed Access

Discontinuation of disease-modifying therapy in MS patients over 60 years old and its impact on relapse rate and disease progression

17

Citations

14

References

2023

Year

Manuel Salavisa, Filipa Serrazina, Filipa Ladeira, Ana Sofia Correia

Clinical Neurology and Neurosurgery

Ms PatientsDisease ProgressionRelapse RateNeurological ProgressDisease-modifying TherapyNeurologyMultiple SclerosisMedicineNeuroimmunology

References

	Year	Citations

Page 1